Staff Computer Vision Engineer
About the job
- A bachelor's degree in Software Engineering, Computer Science, Artificial Intelligence, or a related discipline is required.
- At least 4 years of related work experience is required.
- Design, develop, train, and integrate advanced computer vision and machine learning solutions.
- Train, evaluate, and iterate computer vision models using real-world image and video data.
- Create detailed designs and implement software systems, components, and algorithms.
- Design and execute technical experiments and proof-of-concept demonstrations.
- Provide technical guidance to colleagues and contribute to architecture and design decisions.
- Contribute to the design of scalable AI-enabled systems and inform technical tradeoff discussions.
- Translate customer and business needs into technical solutions and product requirements.
- Evaluate and integrate emerging technologies, frameworks, and tools to accelerate innovation.
- Participate in design reviews, code reviews, and the application of engineering best practices.
- Partner with R&D, Product, Clinical, Quality, Regulatory, and cross-functional stakeholders to deliver impactful solutions.
- Influence technical decisions within assigned projects and partner with senior technical leaders on broader initiatives.
- Contribute to innovation through technical contributions, invention disclosures, and potential patent activity.
- Collaborate with global engineering teams across North America and India.
- Experience developing and deploying computer vision and/or AI/ML solutions in real-world environments.
- Experience training, evaluating, and improving computer vision or machine learning models.
- Experience developing software solutions for complex technical environments.
- Experience applying machine learning to image or video analysis applications.
- Experience with frameworks such as OpenCV, PyTorch, TensorFlow, or similar technologies.
- Experience with Python and/or C++, with CUDA as a plus.
- Excellent communication and collaboration skills with the ability to influence across technical and cross-functional teams.
- Experience with medical imaging.
- Experience with cloud AI/ML environments, model training pipelines, or MLOps workflows.
- Experience working with large-scale datasets and model evaluation strategies.
- Experience in regulated industries such as healthcare, medical devices, aerospace, robotics, automotive, or other safety-critical environments.
- Experience supporting intellectual property development through patents or invention disclosures.
About the company
Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.
Company Size
10,001+
Company Stage
IPO
Headquarters
Kalamazoo, Michigan
Founded
1941
Get referred to Stryker
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 organic sales grew 9%, showing resilient hospital demand across businesses.
- Mako recorded its best-ever second quarter installations in the U.S. and internationally.
- Stryker signed ZuriMED and bought AVS, deepening shoulder and peripheral vascular pipelines.
What critics are saying
- A 2026 cyber incident disrupted production, delayed backorders, and exposed operational fragility.
- Peripheral Vascular supply problems caused lost sales in Q2 2026 and linger into Q3.
- Lakeland closures continue through mid-2027, signaling restructuring pressure and execution drag.
What makes Stryker unique
- Mako surpassed 2.5 million procedures worldwide, reinforcing robotics leadership in orthopedics.
- SportSuite Vision won FDA De Novo authorization for Apple Vision Pro surgical use.
- Stryker combined Ortho Tech in 2026, tightening workflow across Mako and instruments.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical & prescription plans
Supplemental health benefits
Flexible Spending accounts
Employee Assistance Program
Short-term & long-term disability
Tuition reimbursement
401(k) plan
Employee Stock Purchase Plan
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker. “By integrating AVS’s innovative CO₂-generated pressure wave technology with Stryker’s scale and resources, we are well-positioned to deliver solutions that support physicians and patient outcomes.” The addition of an IVL platform will strengthen Stryker’s impact in peripheral vascular solutions. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products
Stryker is launching Prophecy Surgical Planning for its Incompass Total Ankle System and introducing Hoffmann LRF smartHEX at the 2026 American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle. Prophecy has supported patient-specific planning for more than 100,000 ankle cases over 14 years. The platform now offers surgeons 3D visualisation and both resect-through and pin-through fixation options within a single connected platform. The Incompass Total Ankle System was designed using insights from Prophecy and Stryker's orthopaedic modelling analytics, incorporating real-world anatomy into the implant design. Hoffmann LRF smartHEX expands Stryker's limb reconstruction portfolio with new rings, struts and frame components. It includes a mobile app and planning software designed to enhance frame versatility and support connected care for complex deformity correction.
Stryker has completed the first surgical procedure using its FDA-authorized SportSuite Vision application on Apple Vision Pro at Duke Health. The hip arthroscopy was performed by orthopaedic surgeon Dr Chad Mather III at the academic medical centre. SportSuite Vision received FDA De Novo authorization on 17 July, making it the first application approved for intraoperative use with Apple Vision Pro. The technology allows surgeons to view arthroscopic video, HipCheck, HipMap and CT imaging within their field of vision during procedures. The spatial computing application aims to reduce reliance on traditional monitors positioned throughout operating rooms. By bringing multiple data sources into the surgeon's field of view, it supports a more streamlined and ergonomic surgical workflow during complex arthroscopic procedures.
Stryker has signed a definitive agreement to acquire ZuriMED, a privately held developer of the FiberLocker System for rotator cuff repair. The commercialised soft tissue augmentation technology is designed to provide increased biomechanical strength and reduce clinical failure in rotator cuff procedures. According to Stryker, the acquisition will strengthen its shoulder portfolio and expand support for shoulder specialists across sports medicine and arthroplasty. Rotator cuff augmentation is described as one of the fastest-growing areas in sports medicine and a significant opportunity in shoulder care. The transaction is subject to customary closing conditions. Stryker and ZuriMED will operate as separate entities until closing is complete.